PQ 160
160. Deputy Louise O'Reilly asked the Minister for Health when his attention was drawn to the risks associated with the use of valproate in pregnancy; the action taken to minimise these risks in particular prior to 2014 when the European Medicines Agency implemented its first series of risk reduction measures; and his views on the recent study published in a journal (details supplied). [20973/19]
Introduced
15 May 2019
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
15 May 2019
Summary
160. Deputy Louise O'Reilly asked the Minister for Health when his attention was drawn to the risks associated with the use of valproate in pregnancy; the action taken to minimise these risks in particular prior to 2014 when the European Medicines Agency implemented its first series of risk reduction measures; and his views on the recent study published in a journal (details supplied). [20973/19]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Health Services Reports
Health Services Reports
xml · EN · 15 May 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2019-05-15/160/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2019-05-15/pq_160